Sevoflurane inhalant

A technology of sevoflurane and inhalants, which is applied in the field of medicine, can solve problems such as limited commercial application value, and achieve the effect of reducing degradation and good stability

Active Publication Date: 2015-12-02
SHANDONG NEWTIME PHARMA
View PDF18 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] A number of methods for the preparation of sevoflurane have been described, many of which have limited commercial application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sevoflurane inhalant
  • Sevoflurane inhalant

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Sevoflurane 375g

[0024] Ethanol 0.375g

[0025] Peppermint oil 0.75g

[0026] Preparation Process:

[0027] Weigh the prescribed amount of peppermint oil, dissolve it in ethanol, add the prescribed amount of sevoflurane, and fill it in a glass bottle.

Embodiment 2

[0029] Sevoflurane 375g

[0030] Ethanol 1.125g

[0031] Peppermint oil 1.5g

[0032] Preparation Process:

[0033] Weigh the prescribed amount of peppermint oil, dissolve it in ethanol, add the prescribed amount of sevoflurane, and fill it in a glass bottle.

Embodiment 3

[0035] Sevoflurane 375g

[0036] Ethanol 0.75g

[0037] Peppermint oil 1.125g

[0038] Preparation Process:

[0039] Weigh the prescribed amount of peppermint oil, dissolve it in ethanol, add the prescribed amount of sevoflurane, and fill it in a glass bottle.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicine and particularly relates to a sevoflurane inhalant which contains sevoflurane, peppermint oil and ethanol and is prepared through the following method: dissolving peppermint oil in ethanol to form a solution, adding the solution in sevoflurane to form a mixture, and filling the mixture in a glass bottle. Compared with the prior art, the technology is simple, and the stability is excellent.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a sevoflurane inhalation agent. Background technique [0002] The compound sevoflurane (1,1,1,3,3,3-hexafluoroisopropylfluoromethyl ether or hexafluoroisopropylfluoromethyl ether or (CF3)2CHOCH2F) is a widely used inhalational anesthetic, especially Suitable for outpatient surgery. Therefore, a cost-effective method for the preparation of stable sevoflurane is highly desired. [0003] A number of methods for the preparation of sevoflurane have been described, many of which have limited commercial application. U.S. Patent 3,683,092 describes four preparations, three of which start with 1,1,1,3,3,3-hexafluoroisopropylmethyl ether (reaction with potassium fluoride in sulfolane or with bromine trifluoride reaction), one starting with 1,1,1,3,3,3-hexafluoroisopropanol (reaction with formaldehyde and hydrogen fluoride). US Patent 3,897,502 describes the direct fluorina...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/72A61K31/08A61K47/44A61K47/10A61P23/00
Inventor 张贵民张明镜
Owner SHANDONG NEWTIME PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products